Skip to content

Clinical trials

Phase 2 Carcinoma, Squamous Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Phase 2 Clear all

185 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20033
20042
20054
20069
20079
20085
20094
20107
20117
201210
20135
20147
20157
20169
20179
20188
201913
20209
20216
202210
20237
20245
202512
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Terminated30
Recruiting26
Active, not recruiting20
Unknown status20
Withdrawn10
Not yet recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center10
UNC Lineberger Comprehensive Cancer Center8
Cliniques universitaires Saint-Luc- Université Catholique de Louvain5
University of Chicago5
Dana-Farber Cancer Institute4
Massachusetts General Hospital4
Merck Sharp & Dohme LLC4
Amgen3
H. Lee Moffitt Cancer Center and Research Institute3
Memorial Sloan Kettering Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell185
Head and Neck Neoplasms62
Squamous Cell Carcinoma of Head and Neck48
Carcinoma, Non-Small-Cell Lung18
Adenocarcinoma16
Esophageal Neoplasms16
Mouth Neoplasms11
Oropharyngeal Neoplasms11
Recurrence11
Carcinoma10

Trials

Showing 51 to 75 of 185. Each trial links to its page on Pharma Observatory.

85 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.